ESC Premium Access

Meet the Trialists - EMANATE

Event: ESC CONGRESS 2017
Topic: Atrial fibrillation (AF)
Session type: Meet the Trialists
Date: 28 August 2017
Time: 15:40 - 16:00

Session

1 presentations in this session

Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial.

Speaker: Professor M. Ezekowitz (Philadelphia, US)
Thumbnail

1 speaker from this session

Professor Michael D Ezekowitz

Thomas Jefferson University Hospital, Philadelphia (United States of America)
3 presentations
0 follower

This platform is supported by

logo Novo Nordisk